Abilify Maintena PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia.
This product is not listed on the PBS for the treatment of bipolar 1 disorder.

Brintellix PBS information: This product is not listed on the PBS.

REXULTI PBS Information: Authority required (STREAMLINED). Code: 4246 for schizophrenia

Vyepti PBS Information: Authority Required (STREAMLINED). Codes: 14189 for initial treatment and 12029 for continuing treatment.

Lexapro PBS Information: Restricted benefit.
Major Depressive Disorders, moderate to severe Generalised Anxiety Disorder, and moderate to severe Social Anxiety Disorder. Refer to PBS Schedule for full information.

Please review Approved Product Information before prescribing.
Product Information is available by calling Lundbeck on 1300 721 277 or by clicking:

Abilify Maintena PI Brintellix PI REXULTI PI Vyepti PI Lexapro PI

References: 1. Abilify Maintena Australian Product Information. 2. Brintellix Australian Product Information. 3. REXULTI Australian Product Information. 4. Vyepti Australian Product Information. 5. Lexapro Australian Product Information

Abilify Maintena is a registered trademark of Otsuka Pharmaceutical Co., Ltd. Brintellix, REXULTI, Vyepti and Lexapro are registered trademarks of H. Lundbeck A/S. Abilify Maintena® and REXULTI® are co-commercialised by Lundbeck Australia and Otsuka Australia Pharmaceutical Pty Limited.